Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Deligny

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|July 24, 2002
[Cl958]Amélie Lansiaux, Armelle Caty, Nathalie Deligny, et al.
Bulletin Du Cancer|January 7, 2004
[Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas]Nicolas Penel, Gérard Depadt, Marie-Odile Vilain, et al.
Oncology|April 18, 2008
Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancerMohamed Hebbar, Frédéric Di Fioré, Thierry Conroy, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|July 24, 2002
[Cl958]Amélie Lansiaux, Armelle Caty, Nathalie Deligny, et al.
Bulletin Du Cancer|January 7, 2004
[Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas]Nicolas Penel, Gérard Depadt, Marie-Odile Vilain, et al.
Oncology|April 18, 2008
Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancerMohamed Hebbar, Frédéric Di Fioré, Thierry Conroy, et al.
Pageof 1